Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 37: 1762-1766, 1991;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Motti, C.
Right arrow Articles by Assmann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Motti, C.
Right arrow Articles by Assmann, G.

Clinical Chemistry, Vol 37, 1762-1766, Copyright © 1991 by American Association for Clinical Chemistry

Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100

C Motti, H Funke, S Rust, A Dergunov and G Assmann
Institut fur Arterioskleroseforschung, Universitat Munster, F.R.G.

Familial defective apolipoprotein (apo) B-100 is a genetic trait characterized by an Arg----Gln substitution in position 3500 of the apo B sequence. This genetic defect is associated with greatly increased concentrations of plasma cholesterol and may thus increase the risk of developing premature atherosclerotic disease. We describe here the use of mutagenic polymerase chain reaction primers, which greatly facilitate identification of carriers of this mutation. Moreover, we demonstrate that this method may also be used for determining the phase between two polymorphic sites. Using apo B-100 as an example we located on different chromosomes the defect in codon 3500 and a mutation in codon 3611, which produces another Arg----Gln change in the encoded apo B-100 amino acid sequence, in two probands heterozygous for both mutations.


The following articles in journals at HighWire Press have cited this article:


Home page
 Ann Clin BiochemHome page
K. E Liyanage, A. J Hooper, J. C Defesche, J. R Burnett, and F. M van Bockxmeer
High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations
Ann Clin Biochem, March 1, 2008; 45(2): 170 - 176.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Gagne, D. Gaudet, E. Bruckert, and for the Ezetimibe Study Group
Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia
Circulation, May 28, 2002; 105(21): 2469 - 2475.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Bertolini, A. Cantafora, M. Averna, C. Cortese, C. Motti, S. Martini, G. Pes, A. Postiglione, C. Stefanutti, I. Blotta, et al.
Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20 (9): e41 - e52.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. Deiana, R. Garuti, G. M. Pes, C. Carru, A. Errigo, M. Rolleri, L. Pisciotta, P. Masturzo, A. Cantafora, S. Calandra, et al.
Influence of {beta}0-Thalassemia on the Phenotypic Expression of Heterozygous Familial Hypercholesterolemia : A Study of Patients With Familial Hypercholesterolemia From Sardinia
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 236 - 243.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. R. Miserez and U. Keller
Differences in the Phenotypic Characteristics of Subjects With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1719 - 1729.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Association for Clinical Chemistry.